The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-(4)-(ethylsulfonyl)benzoylalanine ID: ALA3629572
PubChem CID: 11652132
Max Phase: Preclinical
Molecular Formula: C12H15NO5S
Molecular Weight: 285.32
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCS(=O)(=O)c1ccc(C(=O)C[C@H](N)C(=O)O)cc1
Standard InChI: InChI=1S/C12H15NO5S/c1-2-19(17,18)9-5-3-8(4-6-9)11(14)7-10(13)12(15)16/h3-6,10H,2,7,13H2,1H3,(H,15,16)/t10-/m0/s1
Standard InChI Key: JLNPBBSGBIACRH-JTQLQIEISA-N
Molfile:
RDKit 2D
19 19 0 0 0 0 0 0 0 0999 V2000
2.5984 2.7004 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5988 1.5004 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
3.6377 2.1009 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5972 -1.5031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5951 -3.0039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6375 -0.9049 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.8933 -3.7570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8912 -5.2578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9336 -3.1588 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.8509 -5.8560 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.9292 -5.8600 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.8990 0.7508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9382 1.3509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
8 10 1 0
10 11 1 0
10 12 2 0
11 13 1 0
13 14 1 0
13 15 1 1
14 16 1 0
14 17 2 0
5 2 1 0
2 18 1 0
18 19 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 285.32Molecular Weight (Monoisotopic): 285.0671AlogP: 0.46#Rotatable Bonds: 6Polar Surface Area: 114.53Molecular Species: ZWITTERIONHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 0.90CX Basic pKa: 8.56CX LogP: -2.38CX LogD: -2.41Aromatic Rings: 1Heavy Atoms: 19QED Weighted: 0.73Np Likeness Score: -0.64
References 1. Dounay AB, Tuttle JB, Verhoest PR.. (2015) Challenges and Opportunities in the Discovery of New Therapeutics Targeting the Kynurenine Pathway., 58 (22): [PMID:26207924 ] [10.1021/acs.jmedchem.5b00461 ] 2. Pellicciari R, Liscio P, Giacchè N, De Franco F, Carotti A, Robertson J, Cialabrini L, Katsyuba E, Raffaelli N, Auwerx J.. (2018) α-Amino-β-carboxymuconate-ε-semialdehyde Decarboxylase (ACMSD) Inhibitors as Novel Modulators of De Novo Nicotinamide Adenine Dinucleotide (NAD+) Biosynthesis., 61 (3): [PMID:29345930 ] [10.1021/acs.jmedchem.7b01254 ]